Sep 26, 2023

Featuring an interview with Dr Debra Richardson, including the following topics:

• Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors (0:00)
• Activity, safety and ongoing investigation of tumor treating fields in combination with chemotherapy for advanced ovarian cancer (5:12)
• ASCO...

Sep 26, 2023

Featuring a slide presentation and related discussion from Dr Debra Richardson, including the following topics:

• Targeting folate receptor alpha in ovarian cancer; activity, tolerability and ongoing investigation of the antibody-drug conjugate (ADC) mirvetuximab soravtansine (0:00)
• Other ADCs under investigation for...

Aug 11, 2023

Featuring a slide presentation and related discussion from Dr Floor J Backes, including the following topics:

• Recent updates from ASCO 2023 in the management of ovarian cancer (0:00)
• Recent updates from ASCO 2023 in the management of endometrial cancer (36:08)
• Recent updates from ASCO 2023 in the management of cervical...

Aug 11, 2023

Featuring perspectives from Dr Floor J Backes, including the following topics:

• Available data with and clinical investigator perspectives on trastuzumab deruxtecan for the management of gynecologic cancers (0:00)
• Patient-specific factors guiding treatment selection and sequencing for ovarian cancer (OC) (6:05)

Jul 14, 2023

Featuring perspectives from Dr Bradley J Monk and Dr Matthew A Powell, including the following topics:

• Introduction (0:00)
• First-Line Therapy for Advanced Endometrial Cancer (EC) — Dr Powell (7:32)
• Current Options for Relapsed EC; Promising Investigational Agents and Strategies — Dr Monk (32:39)
• Clinical Investigator...